This could be evidence that AF16 modifies the TME of glioblastoma to become less pro-malignant while acknowledging that several glioblastoma-associated proteins were upregulated by AF16 treatment (uPA, IL8, etc.). This evidence concerns the gene CXCL8 and glioblastoma.